LEMAITRE VASCULAR INC - Common Stock (LMAT) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
LMAT on Nasdaq
Shares outstanding
18,810,702
Price per share
$81.10
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
20,972,168
Total reported value
$1,835,216,298
% of total 13F portfolios
0%
Share change
-80,983
Value change
-$6,566,680
Number of holders
295
Price from insider filings
$81.10
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of LEMAITRE VASCULAR INC - Common Stock (LMAT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 14% -21% $246,340,581 -$64,346,865 3,102,917 -21% BlackRock, Inc. 31 Mar 2025
LeMaitre George W 7.4% -12% $147,419,609 -$21,118,438 1,684,603 -13% George W. LeMaitre 30 Sep 2025
Conestoga Capital Advisors, LLC 8.1% 0% $123,875,714 -$24,191,963 1,527,429 -16% Conestoga Capital Advisors 31 Dec 2025
Copeland Capital Management, LLC 5.2% $78,515,122 988,980 Copeland Capital Management 31 Dec 2024

As of 30 Sep 2025, 295 institutional investors reported holding 20,972,168 shares of LEMAITRE VASCULAR INC - Common Stock (LMAT). This represents 111% of the company’s total 18,810,702 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of LEMAITRE VASCULAR INC - Common Stock (LMAT) together control 83% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 17% 3,112,875 -2.1% 0% $272,407,699
VANGUARD GROUP INC 8.5% 1,600,087 -0.12% 0% $140,023,613
Conestoga Capital Advisors, LLC 8.4% 1,574,688 -1.8% 2.2% $137,800,958
Copeland Capital Management, LLC 5% 940,328 -5% 1.7% $82,288,209
GENEVA CAPITAL MANAGEMENT LLC 4.8% 912,248 -0.33% 1.4% $79,830,852
FIRST TRUST ADVISORS LP 4.4% 828,947 +35% 0.05% $72,541,151
STATE STREET CORP 4.3% 800,863 -1.2% 0% $70,083,521
CONGRESS ASSET MANAGEMENT CO 3.7% 692,266 +2.7% 0.4% $60,580,220
PRICE T ROWE ASSOCIATES INC /MD/ 2.8% 528,379 +84% 0% $46,239,000
GEODE CAPITAL MANAGEMENT, LLC 2.8% 527,168 +1.4% 0% $46,138,602
DIMENSIONAL FUND ADVISORS LP 2.5% 462,679 +0.36% 0.01% $40,485,834
MORGAN STANLEY 2.2% 421,606 +3.2% 0% $36,894,877
Ranger Investment Management, L.P. 2.1% 385,800 -25% 2.4% $33,761,358
NORTHERN TRUST CORP 1.8% 336,800 -1.9% 0% $29,473,369
ENVESTNET ASSET MANAGEMENT INC 1.5% 290,673 -4.6% 0.01% $25,436,809
ROYAL BANK OF CANADA 1.5% 276,827 -11% 0% $24,225,000
Rockefeller Capital Management L.P. 1.4% 266,479 -7.9% 0.05% $23,319,593
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1.3% 241,936 -0.44% 0.05% $21,171,819
Annex Advisory Services, LLC 1.2% 230,017 +4.7% 0.43% $20,128,771
KENNEDY CAPITAL MANAGEMENT LLC 1.1% 215,867 +32% 0.42% $18,890,521
Russell Investments Group, Ltd. 1.1% 199,264 -23% 0.02% $17,437,721
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.1% 197,634 +2.6% 0% $17,294,951
RENAISSANCE TECHNOLOGIES LLC 0.96% 180,602 +14% 0.02% $15,804,481
DF DENT & CO INC 0.95% 178,430 -5% 0.2% $15,614,447
RICE HALL JAMES & ASSOCIATES, LLC 0.95% 178,186 -17% 0.85% $15,593,013

Institutional Holders of LEMAITRE VASCULAR INC - Common Stock (LMAT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 963,342 $78,164,242 +$6,463,119 $81.10 24
2025 Q3 20,972,168 $1,835,216,298 -$6,566,680 $87.51 295
2025 Q2 21,166,185 $1,758,234,218 +$2,582,647 $83.05 283
2025 Q1 21,129,287 $1,773,183,030 -$3,874,532 $83.90 284
2024 Q4 21,166,541 $1,950,534,663 +$21,370,537 $92.14 304
2024 Q3 20,877,658 $1,938,945,725 +$15,467,005 $92.89 287
2024 Q2 20,542,125 $1,690,113,036 +$26,706,371 $82.28 260
2024 Q1 20,240,838 $1,343,070,412 +$12,044,119 $66.36 242
2023 Q4 40,065 $2,274,091 +$271,881 $56.76 3
2023 Q3 19,480,540 $1,061,371,289 +$24,103,888 $54.48 218
2023 Q2 18,804,333 $1,264,404,597 +$4,492,614 $67.28 207
2023 Q1 18,555,217 $955,048,309 -$1,816,172 $51.47 180
2022 Q4 19,025,533 $875,420,682 -$4,135,179 $46.02 180
2022 Q3 19,087,481 $967,254,442 -$9,000,167 $50.68 181
2022 Q2 19,162,832 $872,948,335 +$29,394,119 $45.55 173
2022 Q1 18,673,917 $867,679,057 +$20,795,197 $46.47 174
2021 Q4 18,319,326 $918,674,207 -$2,802,400 $50.23 177
2021 Q3 18,623,610 $988,999,311 +$46,872,947 $53.09 191
2021 Q2 17,612,728 $1,073,680,907 -$8,468,856 $61.02 182
2021 Q1 17,933,155 $875,509,917 +$18,306,355 $48.78 178
2020 Q4 17,471,539 $708,360,963 +$12,871,754 $40.50 163
2020 Q3 17,286,782 $562,389,201 +$13,712,782 $32.53 135
2020 Q2 16,847,952 $444,929,145 +$84,792 $26.40 141
2020 Q1 16,710,960 $416,634,467 -$40,674,824 $24.92 134
2019 Q4 17,296,257 $621,760,984 +$53,630,088 $35.95 155
2019 Q3 15,796,391 $539,917,367 +$10,928,737 $34.18 142
2019 Q2 15,477,453 $433,165,019 +$11,044,019 $27.98 144
2019 Q1 15,094,256 $467,901,143 +$5,916,737 $31.00 146
2018 Q4 14,757,300 $348,812,642 -$33,637,986 $23.64 133
2018 Q3 15,895,844 $615,731,972 +$22,582,642 $38.74 147
2018 Q2 15,392,778 $515,539,608 +$44,922,487 $33.48 157
2018 Q1 14,110,623 $511,452,928 +$11,857,700 $36.23 151
2017 Q4 13,813,899 $440,038,226 +$16,412,891 $31.84 133
2017 Q3 13,382,546 $500,633,095 +$31,317,276 $37.42 145
2017 Q2 12,624,931 $394,127,013 +$30,008,876 $31.22 139
2017 Q1 11,695,921 $288,085,788 +$39,811,384 $24.63 113
2016 Q4 11,084,873 $280,867,485 -$389,037 $25.34 109
2016 Q3 11,333,706 $224,855,790 +$6,578,954 $19.84 107
2016 Q2 11,044,377 $157,602,884 +$5,445,534 $14.27 96
2016 Q1 10,695,804 $165,991,000 +$7,839,796 $15.52 94
2015 Q4 10,161,715 $175,317,131 +$4,516,210 $17.25 90
2015 Q3 10,148,220 $123,698,280 +$3,211,819 $12.19 83
2015 Q2 9,346,147 $112,713,982 +$9,487,378 $12.06 74
2015 Q1 8,372,852 $70,163,000 +$1,710,755 $8.38 47
2014 Q4 8,171,831 $62,515,000 +$2,242,265 $7.65 44
2014 Q3 7,399,475 $50,910,000 -$284,073 $6.88 38
2014 Q2 7,437,511 $61,511,143 +$2,544,462 $8.27 39
2014 Q1 6,132,021 $49,463,700 +$886,604 $8.07 42